
Spartan is pleased to have received the above plaque from Dr. Kitts of The Ottawa Hospital (TOH). TOH has been a key partner in the validation of the Spartan DXTM DNA analyzer. Donating a DX device to TOH was our small way of saying thank you to the hospital and the scientists who donated their time and lab space for the validation project. Spartan looks forward to continuing our mutually beneficial relationship with TOH.
From left to right: Paul Markell, Chief Operating Officer, Spartan Bioscience; Mark D. Kershey, VP Corporate Development, Spartan Bioscience; Paul Lem, M.D., CEO & Founder, Spartan Bioscience; Dr. Jack Kitts, President and CEO, The Ottawa Hospital.
“The Spartan-HSV assay is reliable and reproducible, with performance equaling conventional real-time HSV PCR. The Spartan DXTM is an excellent choice for laboratories wanting an a… ”
Dr. Tim Karnauchow, Ph.D.
Clinical Virologist
Children’s Hospital of Eastern Ontario
“The Spartan DX is a new real-time PCR instrument that is ideal for use in laboratories wishing to perform non-batched (”stat”) molecular testing. This instrument provides rapid and… ”
Dr. Karam Ramotar, Ph.D.
Molecular Microbiologist
Ottawa Hospital, General Campus.
Albuquerque, New Mexico / August 12-13, 2008 / Booth #304
http://chppm-www.apgea.army.mil/fhp/
Grapevine, Texas / August 12-13, 2008 / Booth #215
http://www.amp.org/2008/index.htm/